The peptide problem: Hype is outrunning the evidence FDA takes first step in possible reversal of ban on some peptides The Washington Post Is the lack of human data in BPC 157 a red flag? If a drug could actually knit torn tendons back together in weeks, a trillion dollar pharmaceutical industry probably wouldn't bury Everyone online is suddenly injecting peptides. But almost nobody understands the scienceor the regulation. The FDA recently shifted several peptides off the Category 2 safety risk list tied to compounding rules. First, that